medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2020, Number 6

<< Back Next >>

Rev Mex Urol 2020; 80 (6)

Clinical characteristics and prognostic factors of emphysematous pyelonephritis: a therapeutic experience at a tertiary care hospital center in Mexico

Sánchez-Núñez JE, Rico-Frontana E, Hernández-Calderón FJ, Cabrera-Mora NA, Rodríguez-Sánchez Y, Flores-García LR, Flores-Valle Y, Hernández-Hernández RA, Virgen-Gutiérrez JF, Rosas NJE, Acevedo GC, Jaspersen-Gastélum J

Language: Spanish
References: 12
Page: 1-9
PDF size: 582.92 Kb.


ABSTRACT

Introduction: Emphysematous pyelonephritis (EP) is a necrotizing infection of the upper urinary tract, associated with enterobacteria, whose progression is subacute and insidious. Diagnosis is clinical and is corroborated and staged through computed tomography. Management depends on the severity of the case and can range from antimicrobial therapy and surveillance to emergency nephrectomy.
Aim: To describe the factors associated with the severity of EP in a population seen at the Urology Service of the Hospital General de México.
Materials and methods: A retrospective, observational, analytic study was conducted. The qualitative variables were expressed through simple frequencies and percentage distribution and the quantitative variables were expressed through measures of central tendency. The variables with non-normal distribution were expressed through median and interquartile range. Group comparisons were carried out using the Fisher’s exact test (qualitative variables), the Mann-Whitney U test, and 95% confidence intervals (95% CIs). Odds ratios (ORs) were utilized for the inferential statistics to obtain the relation of each factor to severity. Calculations were made with a 95% CI and a 5% alpha error.
Results: The factors associated with EP severity were: bilaterality (OR 7.5, 95% CI 1.56- 36.8, p 0.011), renal colic (OR 2.9, 95% CI 0.70-12.4, p 0.01), leukocytosis (OR 1.5, 95% CI 0.44-4.92, p 0.04), thrombocytopenia (OR 3.2, 95% CI 0.29-34.7, p 0.04), Glasgow coma score ‹ 15 (OR 1.3, 95% CI 0.31-3.39, p 0.001), and azotemia (OR 1.5, 95% CI 0.44-4.92, p 0.04).
Conclusion: The early identification of those factors can reduce the risk for complications and improve disease progression in patients with EP.


REFERENCES

  1. Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med. 2002;113 Suppl 1A:14S-19S. doi: 10.1016/s0002-9343(02)01055-0

  2. Huang JJ, Tseng CC. Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis. Arch Intern Med. 2000;160(6):797–805. doi: 10.1001/archinte.160.6.797

  3. Boyko EJ, Fihn SD, Scholes D, Chen C-L, Normand EH, Yarbro P. Diabetes and the risk of acute urinary tract infection among postmenopausal women. Diabetes Care. 2002;25(10):1778–83. doi: 10.2337/ diacare.25.10.1778

  4. Ubee SS, McGlynn L, Fordham M. Emphysematous pyelonephritis. BJU Int. 2011;107(9):1474–8. doi: 10.1111/j.1464- 410X.2010.09660.x

  5. Kapoor R, Muruganandham K, Gulia AK, Singla M, Agrawal S, Mandhani A, et al. Predictive factors for mortality and need for nephrectomy in patients with emphysematous pyelonephritis. BJU Int. 2010;105(7):986–9. doi: 10.1111/j.1464-410X.2009.08930.x

  6. Lu Y-C, Chiang B-J, Pong Y-H, Chen C-H, Pu Y-S, Hsueh P-R, et al. Emphysematous pyelonephritis: clinical characteristics and prognostic factors. Int J Urol. 2014;21(3):277– 82. doi: 10.1111/iju.12244

  7. Yap X-H, Ng C-J, Hsu K-H, Chien C-Y, Goh ZNL, Li C-H, et al. Predicting need for intensive care unit admission in adult emphysematous pyelonephritis patients at emergency departments: comparison of five scoring systems. Sci Rep. 2019;9(1):16618. doi: 10.1038/s41598-019-52989-7

  8. Kangjam SM, Irom KS, Khumallambam IS, Sinam RS. Role of Conservative Management in Emphysematous Pyelonephritis - A Retrospective Study. J Clin Diagn Res. 2015;9(11):PC09-PC11. doi: 10.7860/JCDR/2015/16763.6795

  9. Olvera-Posada D, Armengod-Fischer G, Vázquez-Lavista LG, Maldonado-Ávila M, Rosas-Nava E, Manzanilla-García H, et al. Emphysematous pyelonephritis: multicenter clinical and therapeutic experience in Mexico. Urology. 2014;83(6):1280–4. doi: 10.1016/j. urology.2014.02.010

  10. Sharma PK, Sharma R, Vijay MK, Tiwari P, Goel A, Kundu AK. Emphysematous pyelonephritis: Our experience with conservative management in 14 cases. Urol Ann. 2013;5(3):157–62. doi: 10.4103/0974-7796.115734

  11. Saadi A, Ayed H, Bouzouita A, Cherif M, Kerkeni W, Selmi S, et al. Résultats du traitement conservateur de la pyélonéphrite emphysémateuse. Néphrologie & Thérapeutique. 2016;12(7):508–15. doi: 10.1016/j.nephro.2016.05.007

  12. Torres-Mercado LO, García-Padilla MÁ, Serrano-Brambila E, Maldonado-Alcaraz E, López-Sámano VA, Montoya-Martínez G, et al. Factores pronósticos de morbimortalidad en pacientes con pielonefritis enfisematosa. Rev Med Inst Mex Seguro Soc. 2017;54(S2):156–61.




2020     |     www.medigraphic.com